An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

KYPROLIS®

Drug Information Related Patent
Hold Company
AMGEN
Learn More
Dosage and Administration
POWDER;INTRAVENOUS
Specification
60MG/VIAL;30MG/VIAL;10MG/VIAL
Indication
KYPROLIS® is used to treat adult patients with relapsed or refractory multiple myeloma.
Use
Instructions for Use
API
CARFILZOMIB
API Structure
We Supply
CARFILZOMIB
Note:

In-house Standard
Facility GMP
USMF

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
72328182025/4/14
74170422026/7/20
74917042025/4/14
77371122027/12/7
81293462025/4/14
82071252025/4/14
82071262025/4/14
82071272025/4/14
82072972025/4/14
94935822033/2/27
95111092029/10/21
RE479542029/10/21
API Patent
Patent NoExpiration Date
72328182025/4/14
74170422026/7/20
74917042025/4/14
77371122027/12/7
81293462025/4/14
82071252025/4/14
82071262025/4/14
82071272025/4/14
82072972025/4/14

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top